Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China · Delayed Price · Currency is CNY 213.76
-23.03 (-9.73%)
Aug 27, 2025, 2:45 PM CST
Beijing Hotgen Biotech Market Cap
Beijing Hotgen Biotech has a market cap or net worth of 18.83 billion as of August 27, 2025. Its market cap has increased by 726.86% in one year.
Market Cap
18.83B
Enterprise Value
17.66B
Revenue
488.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
213.76
Market Cap Chart
Since September 30, 2019, Beijing Hotgen Biotech's market cap has increased from 4.41B to 18.83B, an increase of 327.11%. That is a compound annual growth rate of 27.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 18.83B | 239.94% |
| Dec 31, 2024 | 5.54B | 50.94% |
| Dec 29, 2023 | 3.67B | -34.53% |
| Dec 30, 2022 | 5.61B | -22.40% |
| Dec 31, 2021 | 7.22B | 197.90% |
| Dec 31, 2020 | 2.43B | 10.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 440.86B |
| Shenzhen Mindray Bio-Medical Electronics | 296.91B |
| WuXi AppTec | 292.07B |
| Sichuan Biokin Pharmaceutical | 132.33B |
| Zhangzhou Pientzehuang Pharmaceutical., | 129.10B |
| Aier Eye Hospital Group | 127.82B |
| Shanghai United Imaging Healthcare | 111.40B |
| Yunnan Baiyao Group Co.,Ltd | 103.47B |